TB-500 (Thymosin Beta-4) Research Overview: Mechanisms and Study Models
TB-500 is the research-market name for synthetic thymosin beta-4 (Tβ4) and its active fragments. Tβ4 is a naturally abundant human protein whose mechanism has been mapped in detail. That gives the literature an unusual degree of coherence for a research peptide.
Mechanism: actin sequestration
Thymosin beta-4 is a 43-amino-acid peptide and the body's principal G-actin sequestering molecule. It binds monomeric actin and regulates its polymerization into filaments. Actin dynamics drive cell shape, division and movement, placing Tβ4 directly upstream of cell migration. The short central fragment containing the LKKTETQ actin-binding motif reproduces much of this activity; it is the basis of several synthetic versions sold for research.
What the studies have examined
- Dermal wound healing. This is the foundational work. In rodent models, including diabetic and aged animals, topical and systemic Tβ4 accelerated wound closure, increased keratinocyte and endothelial migration, and improved collagen deposition.
- Corneal repair. Tβ4 promoted re-epithelialization in corneal injury models. That work progressed into human trials of Tβ4 eye drops (RGN-259) for dry eye and neurotrophic keratopathy, making it one of the few thymosin programs to reach clinical stages.
- Cardiac models. After coronary ligation in mice, Tβ4 supported cardiomyocyte survival and epicardial progenitor activation. This remains an active preclinical area.
- Anti-fibrotic and anti-inflammatory effects. Reduced scar formation and inflammatory infiltration have been reported across several organ injury models.
Where the evidence stops
Outside the ophthalmic programs, Tβ4 research remains preclinical. No injectable TB-500 product is approved for human or veterinary use, and sports anti-doping agencies explicitly prohibit it. Regardless of their consistency, published animal results do not establish human efficacy or safety.
Laboratory handling
TB-500 reconstitutes cleanly in bacteriostatic water and follows standard storage practice: keep it refrigerated and dark, and use it within the 30-day window. Its larger size relative to short peptides calls for gentler handling during reconstitution. Swirl; never shake.
We stock independently tested TB-500 (10mg vials) and the BPC-157 + TB-500 combo vial. For how TB-500 differs from BPC-157 mechanistically, read the side-by-side comparison. For research use only — not for human or veterinary use.